Clinical Trials Browser

Phase 4 × Neoplasms × Sorafenib × Clear all

NCT00352859 2014-12-30

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Phase 4 Terminated

Carcinoma, Renal Cell, Neoplasms